Skip to main content

Cardiovascular Diabetology's 15th Anniversary

Nowadays, it is widely accepted in the scientific community that there is a striking and even overlapping, interrelationship between heart diseases and alterations in glucose metabolism; particularly in pre-diabetes, diabetes and the metabolic syndrome. Based on 20 years of surveillance, the well-known Framingham Heart Study reported a two- to threefold increase in the incidence of cardiovascular disease and stroke in diabetic patients, compared to their non-diabetic counterparts. Furthermore, the American Heart Association officially stated in 1999 that "diabetes is a cardiovascular disease equivalent".  Indeed, diabetes and atherosclerosis share many genetic and environmental antecedents, namely the so-called “common soil”.

In this context, professors Alexander Tenenbaum and Enrique Fisman conceived in 2001 the idea of creating a scientific journal specifically dedicated to this issue.  Following their initiative, the journal Cardiovascular Diabetology was launched in April 2002 with the enthusiastic support of BioMed Central (now a part of Springer Nature). Since then, Cardiovascular Diabetology has been growing rapidly, and fortunately became a prestigious international journal that has published more than 1250 scientific articles - some of them representing a major breakthrough in their particular fields. The journal is privileged to have a high-status Editorial Board, a rigorous peer review policy, a multidisciplinary audience, high visibility and ample global exposure. 

We are now celebrating the journal’s 15 year anniversary and are looking forward to future advancements. April 2002 may also be considered as the official "birthday" of a novel medical area - cardiovascular diabetology - a discipline specifically dedicated to fight against cardio-diabetes and metabolism-related cardiovascular diseases.  On this occasion, Cardiovascular Diabetology would like to express its gratitude to the worldwide recognized scientists on its Editorial Board, the authors, the publisher’s staff, the reviewers and the readership for their continuous backing and assistance.
We believe that the rapid progress of cardiovascular diabetology will lead to even more impressive achievements in both basic and clinical science, which will be reflected in improved public health.

The future looks encouraging.

Click to read more

Our anniversary collection: the 20 most influential articles in Cardiovascular Diabetology

Read the most influential articles published in the journal from throughout our fifteen year history.

What do those in the field think of Cardiovascular Diabetology?

"I have the privilege of being a member of the Editorial Board of Cardiovascular Diabetology since its launching in 2002, and cooperated also with the journal as an author and a reviewer. Hitherto, the journal has grown enormously becoming a world known scientific publication with high Impact Factor. It is the most important journal bridging between cardiovascular disease and diabetes. On its fifteenth anniversary Cardiovascular Diabetology has become an important reference for relevant scientific developments in its field. Congratulations and best wishes to the editors, the editorial committee and the publisher!"

Ricardo J. Esper, MD, PhD
Professor of Medicine & Cardiology, Buenos Aires University, Buenos Aires, Argentina
Past President, Sociedad Argentina de Cardiología & Interamerican Heart Foundation

"I think the journal Cardiovascular Diabetology is one of the few that focuses on the interrelationship between diabetes, metabolic syndrome and associated cardiovascular complications, which represent one of the leading causes of death in such patients. Therefore, based on the importance of its scope, the speed at which it answers and with its Impact Factor on the rise, it is an attractive option when it comes to submitting a paper in this area." 

Almudena Gómez-Hernández, PhD
Lecturer of Biochemistry and Molecular Biology
Pharmacy School, Complutense University of Madrid, Madrid, Spain

"As a reader, an author and a reviewer, I would like to congratulate Cardiovascular Diabetology for this outstanding first fifteen years. Given the ongoing revolution in treatment of diabetes, and the understanding of its association with the cardiovascular system, I am sure that Cardiovascular Diabetology will be one of the most relevant topics in Medicine in the near future."

Professor Ricardo Fontes-Carvalho
Cardiologist, University of Porto, Porto, Portugal

"Cardiovascular Diabetology has contributed greatly to send novel insights connecting cardiologists with diabetologists to in many ways. Cardiovascular Diabetology will continue to provide fruitful scientific knowledge further in the future. Congratulations."

Norikazu Maeda, MD, PhD
Department of Metabolism and Atherosclerosis, Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 8.5
    5-year Journal Impact Factor: 8.9
    Source Normalized Impact per Paper (SNIP): 1.855
    SCImago Journal Rank (SJR): 2.621

    Speed 2023
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 56

    Usage 2023
    Downloads: 2,523,778
    Altmetric mentions: 3,115